+ |
HPN | up-regulates activity
cleavage
|
F7 |
0.353 |
Identifier |
Residue |
Sequence |
Organism |
Cell Line |
SIGNOR-263638 |
Arg212 |
NASKPQGrIVGGKVC |
in vitro |
|
pmid |
sentence |
7814421 |
Hepsin, a putative membrane-associated serine protease, activates human factor VII and initiates a pathway of blood coagulation on the cell surface leading to thrombin formation|In contrast, an activation cleavage site factor VII mutant, R152E factor VII, was not cleaved by hepsin-transfected cells, suggesting that factor VII and S344A factor VII were activated on these cells by cleavage of the Arg152-Ile153 peptide bond. I |
|
Publications: |
1 |
Organism: |
In Vitro |
+ |
F10 | up-regulates activity
cleavage
|
F7 |
0.52 |
Identifier |
Residue |
Sequence |
Organism |
Cell Line |
SIGNOR-263523 |
Arg212 |
NASKPQGrIVGGKVC |
Homo sapiens |
|
pmid |
sentence |
12524220 |
The factor VII zymogen is cleaved at arginine 152 by a variety of proteases, including thrombin, factor IXa, factor Xa, and factor VIIa–tissue factor to produce the serine protease factor VIIa. |
|
Publications: |
1 |
Organism: |
Homo Sapiens |
Tissue: |
Blood Plasma |
Pathways: | Vitamin-K cycle |
+ |
Factor FVIIa:TF | up-regulates activity
cleavage
|
F7 |
0.932 |
Identifier |
Residue |
Sequence |
Organism |
Cell Line |
SIGNOR-263521 |
Arg212 |
NASKPQGrIVGGKVC |
Homo sapiens |
|
pmid |
sentence |
12524220 |
The factor VII zymogen is cleaved at arginine 152 by a variety of proteases, including thrombin, factor IXa, factor Xa, and factor VIIa–tissue factor to produce the serine protease factor VIIa. |
|
Publications: |
1 |
Organism: |
Homo Sapiens |
Tissue: |
Blood Plasma |
+ |
F9 | up-regulates activity
cleavage
|
F7 |
0.529 |
Identifier |
Residue |
Sequence |
Organism |
Cell Line |
SIGNOR-263522 |
Arg212 |
NASKPQGrIVGGKVC |
Homo sapiens |
|
pmid |
sentence |
12524220 |
The factor VII zymogen is cleaved at arginine 152 by a variety of proteases, including thrombin, factor IXa, factor Xa, and factor VIIa–tissue factor to produce the serine protease factor VIIa. |
|
Publications: |
1 |
Organism: |
Homo Sapiens |
Tissue: |
Blood Plasma |
Pathways: | Vitamin-K cycle |
+ |
GGCX | up-regulates activity
carboxylation
|
F7 |
0.675 |
Identifier |
Residue |
Sequence |
Organism |
Cell Line |
SIGNOR-265919 |
|
|
Homo sapiens |
|
pmid |
sentence |
31226734 |
Thus, vitamin K acts as a cofactor for GGCX via the vitamin K cycle and exerts physiological effects through its regulation of VKDPs [29]. More than 20 VKDPs have been found. Osteocalcin promotes bone formation, and blood coagulation factors II, VII, IX, and X activate blood coagulation. Matrix Gla protein suppresses cardiovascular calcification, and brain-expressed Gas 6 promotes neural differentiation [29]. GGCX is an enzyme that converts glutamic acid (Glu) residues to Gla residues, so that the Gla-containing proteins can exert various physiological actions such as blood coagulation and bone formation. |
|
Publications: |
1 |
Organism: |
Homo Sapiens |
Pathways: | Vitamin-K cycle |
+ |
F7 | up-regulates activity
binding
|
F10 |
0.52 |
Identifier |
Residue |
Sequence |
Organism |
Cell Line |
SIGNOR-263545 |
|
|
Homo sapiens |
|
pmid |
sentence |
29880919 |
TF has a high affinity for FVII and enables the trace levels (∼1% of the total FVII) of activated FVII (FVIIa) in the blood to cleave specific sites in the serine proteases FIX and FX, activating them into FIXa and FXa, respectively. |
|
Publications: |
1 |
Organism: |
Homo Sapiens |
Tissue: |
Blood Plasma |
Pathways: | Vitamin-K cycle |
+ |
PROC | down-regulates activity
cleavage
|
F7 |
0.238 |
Identifier |
Residue |
Sequence |
Organism |
Cell Line |
SIGNOR-263527 |
|
|
Homo sapiens |
|
pmid |
sentence |
29880919 |
Activated protein C (APC), which cleaves and inactivates both FVIIIa and FVa, thereby shutting down both the tenase and prothrombinase complexes |
|
Publications: |
1 |
Organism: |
Homo Sapiens |
Tissue: |
Blood Plasma |
Pathways: | Vitamin-K cycle |
+ |
F7 | form complex
binding
|
Factor FVIIa:TF |
0.932 |
Identifier |
Residue |
Sequence |
Organism |
Cell Line |
SIGNOR-263555 |
|
|
Homo sapiens |
|
pmid |
sentence |
32665005 |
During vascular injury, TF is exposed to the blood, where it functions as a cofactor for the circulating zymogen factor VII (FVII). This TF:FVIIa complex can then bind and activate either factor IX (FIX) or factor X (FX), triggering a cascade that generates fibrin and activates platelets, resulting in a hemostatic plug at the site of injury. |
|
Publications: |
1 |
Organism: |
Homo Sapiens |
Tissue: |
Blood Plasma |
+ |
F2 | up-regulates activity
|
F7 |
0.306 |
Identifier |
Residue |
Sequence |
Organism |
Cell Line |
SIGNOR-263529 |
|
|
Homo sapiens |
|
pmid |
sentence |
29880919 |
Thrombin also activates the cofactors FVIII (to FVIIIa) and FV (to FVa) and activates platelets such that they provide a procoagulant membrane surface to which these proteins then bind |
|
Publications: |
1 |
Organism: |
Homo Sapiens |
Tissue: |
Blood Plasma |
Pathways: | Vitamin-K cycle |
+ |
F7 | up-regulates activity
binding
|
F9 |
0.529 |
Identifier |
Residue |
Sequence |
Organism |
Cell Line |
SIGNOR-263544 |
|
|
Homo sapiens |
|
pmid |
sentence |
29880919 |
TF has a high affinity for FVII and enables the trace levels (∼1% of the total FVII) of activated FVII (FVIIa) in the blood to cleave specific sites in the serine proteases FIX and FX, activating them into FIXa and FXa, respectively. |
|
Publications: |
1 |
Organism: |
Homo Sapiens |
Tissue: |
Blood Plasma |
Pathways: | Vitamin-K cycle |